Melanoma: the role of surgery in the era of new therapies.
作者信息
Mozzillo Nicola, Ascierto Paolo A
机构信息
Department of Melanoma and Soft Tissue, Istituto Nazionale Tumori Fondazione "G, Pascale", Via Mariano Semmola, 80131 Naples, Italy.
出版信息
J Transl Med. 2014 Jul 11;12:195. doi: 10.1186/1479-5876-12-195.
Abstract
摘要
相似文献
1
Melanoma: the role of surgery in the era of new therapies.黑色素瘤：手术在新疗法时代的作用。
J Transl Med. 2014 Jul 11;12:195. doi: 10.1186/1479-5876-12-195.
2
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma.伊匹单抗诱发转移性黑色素瘤患者发生重症肌无力
J Clin Oncol. 2015 Nov 20;33(33):e122-4. doi: 10.1200/JCO.2013.51.1683. Epub 2014 Apr 28.
3
4
Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma.一名高危黑色素瘤患者出现的与伊匹单抗相关的Sweet综合征。
J Am Acad Dermatol. 2014 Apr;70(4):e85-e86. doi: 10.1016/j.jaad.2013.11.022.
5
Systemic therapy for metastatic melanoma in 2012: dawn of a new era.2012 年转移性黑色素瘤的系统治疗：新时代的曙光。
J Natl Compr Canc Netw. 2012 Mar;10(3):403-12. doi: 10.6004/jnccn.2012.0037.
6
Stage IV melanoma.IV期黑色素瘤。
J Neurosurg. 2012 Aug;117(2):225-6; discussion 226. doi: 10.3171/2012.2.JNS1288. Epub 2012 Jun 15.
7
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.立体定向放疗治疗免疫检查点抑制剂治疗时代的黑色素瘤脑转移瘤及可能的生存延长。
J Neurosurg. 2012 Aug;117(2):227-33. doi: 10.3171/2012.5.JNS111929. Epub 2012 Jun 15.
8
Ipilimumab approved for metastatic melanoma.伊匹单抗获批用于治疗转移性黑色素瘤。
Am J Health Syst Pharm. 2011 May 1;68(9):768. doi: 10.2146/news110025.
9
Novel therapies for unresectable and metastatic melanoma.不可切除及转移性黑色素瘤的新型疗法
BMJ. 2017 Nov 30;359:j5174. doi: 10.1136/bmj.j5174.
10
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.高危III期黑色素瘤完全切除术后辅助使用伊匹单抗与安慰剂相比的健康相关生活质量（EORTC 18071）：一项多国、随机、双盲、3期试验的次要结果
Lancet Oncol. 2017 Mar;18(3):393-403. doi: 10.1016/S1470-2045(17)30015-3. Epub 2017 Feb 3.
引用本文的文献
1
Melanoma Management: From Epidemiology to Treatment and Latest Advances.黑色素瘤管理：从流行病学到治疗及最新进展
Cancers (Basel). 2022 Sep 24;14(19):4652. doi: 10.3390/cancers14194652.
本文引用的文献
1
What have we learned from cancer immunotherapy in the last 3 years?在过去三年里，我们从癌症免疫疗法中学到了什么？
J Transl Med. 2014 May 21;12:141. doi: 10.1186/1479-5876-12-141.
2
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.在晚期黑色素瘤患者中，依匹单抗治疗期间的免疫学和生物学变化及其与临床反应和生存的潜在相关性。
Cancer Immunol Immunother. 2014 Jul;63(7):675-83. doi: 10.1007/s00262-014-1545-8. Epub 2014 Apr 3.
3
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.维莫非尼治疗 BRAF(V600) 突变转移性黑色素瘤患者：一项开放性、多中心、安全性研究。
Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27.
4
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.维莫非尼治疗 BRAF(V600E) 和 BRAF(V600K) 突变阳性黑色素瘤（BRIM-3）的安全性和疗效：一项 3 期、随机、开放标签研究的随访扩展。
Lancet Oncol. 2014 Mar;15(3):323-32. doi: 10.1016/S1470-2045(14)70012-9. Epub 2014 Feb 7.
5
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).远处转移性黑色素瘤的转移切除术：来自第一多中心选择性淋巴结切除术试验（MSLT-I）的数据分析。
Ann Surg Oncol. 2012 Aug;19(8):2547-55. doi: 10.1245/s10434-012-2398-z. Epub 2012 May 31.
6
The role of BRAF V600 mutation in melanoma.BRAF V600 突变在黑色素瘤中的作用。
J Transl Med. 2012 Jul 9;10:85. doi: 10.1186/1479-5876-10-85.
7
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.在 IV 期黑色素瘤完全切除术后辅助免疫治疗的 III 期试验中评估预后循环肿瘤细胞。
Ann Surg. 2012 Feb;255(2):357-62. doi: 10.1097/SLA.0b013e3182380f56.
8
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application.抗 CTLA-4 单克隆抗体：临床应用的过去与未来。
J Transl Med. 2011 Nov 13;9:196. doi: 10.1186/1479-5876-9-196.
9
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.依匹单抗联合达卡巴嗪治疗未经治疗的转移性黑色素瘤。
N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5.
10
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.BRAF V600E 突变型黑色素瘤患者采用威罗菲尼治疗后生存改善。
N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.
Zotero 插件